Found 341 articles for: "Open Access"
FULL SUPPLEMENT: Emerging Topical Approaches in the Management of Female Pattern Hair Loss
June 2026 | Volume 25 | Issue 6 | Department | 83250s1 | Copyright © June 2026
Alopecia can be categorized as cicatricial and non-cicatricial, with female androgenetic alopecia (AGA) and female pattern hair loss (FPHL) included in the latter category....
Read MoreINDIVIDUAL ARTICLE: Efficacy of a Dual-Serum Cosmetic System in Women With Female Pattern Hair Loss
June 2026 | Volume 25 | Issue 6 | Supplement Individual Articles | 83251s3 | Copyright © June 2026
Hair loss is a widespread condition with a potentially severe psychological burden, especially among women. The chance of suffering from female alopecia increases with menopause, and topical trea...
Read MoreSafety and Effectiveness of Two Reconstitution Volumes of Poly-L-Lactic Acid for Correction of Décolletage Wrinkles
June 2026 | Volume 25 | Issue 6 | Original Article | 553 | Copyright © June 2026
Background: Aesthetic patients are increasingly aware of the contrast between rejuvenated facial skin and untreated aging skin of the décolletage, and frequently request c...
Read MoreEfficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne
June 2026 | Volume 25 | Issue 6 | Original Article | 545 | Copyright © June 2026
Background: Clascoterone cream 1% is a topical androgen receptor inhibitor approved for the treatment of acne vulgaris in patients ≥12 years of age. The American Academy of De...
Read MoreEfficacy and Safety of Clascoterone Cream 1% and Clindamycin 1.2%/Benzoyl Peroxide 5% Gel Treatment in Patients With Acne
June 2026 | Volume 25 | Issue 6 | Original Article | 537 | Copyright © June 2026
Background: Clascoterone cream 1% is a topical androgen receptor inhibitor approved to treat acne vulgaris in patients ≥12 years of age. The American Academy of Dermatology re...
Read MoreA Review of the Relationship Between Cutibacterium acnes, Biofilms, and Keratosis Pilaris
June 2026 | Volume 25 | Issue 6 | Features | e53 | Copyright © June 2026
Efficacy and Safety of Cosibelimab for Advanced Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel
May 2026 | Volume 25 | Issue 5 | Original Article | 413 | Copyright © May 2026
Background: Cutaneous squamous cell carcinoma (cSCC) represents a significant clinical challenge in patients with locally advanced (laCSCC) or metastatic (mCSCC) disease who are ...
Read MoreSafety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ
May 2026 | Volume 25 | Issue 5 | Original Article | 454 | Copyright © May 2026
Background: Squamous cell carcinoma in situ (isSCC) is an early-stage cutaneous malignancy that requires effective treatment to prevent progression to invasive SCC. Aminolevulini...
Read MoreTreatment of Confluent and Reticulated Papillomatosis Using Fixed-Dose Clindamycin phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel
May 2026 | Volume 25 | Issue 5 | Case Reports | 474 | Copyright © May 2026
Introduction: Confluent and reticulated papillomatosis (CARP) is a rare, non-systemic disease usually treated using oral antibiotics.Case Presentation:Read MorePembrolizumab as an Off-Label Treatment of Facial Angiosarcoma: A Case Report
May 2026 | Volume 25 | Issue 5 | Case Reports | 471 | Copyright © May 2026
Summary of Case: We report an atypical case of cutaneous angiosarcoma presenting as unilateral nasal swelling in an elderly male. The lesion was unresponsive to topical and antib...
Read MoreAn Investigator-Developed Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color
April 2026 | Volume 25 | Issue 4 | Original Article | 330 | Copyright © April 2026
Background: There is an unmet demand for a post-inflammatory hyperpigmentation (PIH) treatment and prevention that is not only effective and accessible, but also safe to use in d...
Read MoreBeyond Efficacy: 0.6% Selenium Disulfide Shampoo Matches 2% Ketoconazole for Seborrheic Dermatitis with Superior Cosmesis
April 2026 | Volume 25 | Issue 4 | Original Article | 338 | Copyright © April 2026
Background: Although most dandruff shampoos are effective, many leave hair dry and unmanageable, potentially impacting patient compliance and treatment outcomes.Obje...
Read MoreEfficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
March 2026 | Volume 25 | Issue 3 | Original Article | 204 | Copyright © March 2026
Alopecia areata (AA) is an autoimmune disease characterized by nonscarring hair loss on the scalp and body, leading to a reduced quality of life and psychosocial burden for patients. The only US ...
Read MoreFULL SUPPLEMENT: A Novel Oral Treatment for Psoriasis: Deucravacitinib
February 2026 | Volume 25 | Issue 2 | Department | 070211s1 | Copyright © February 2026
INDIVIDUAL ARTICLE: Evidence-Based Synthesis of Deucravacitinib: Long Term Efficacy, Safety, and Practical Use in Moderate-to-Severe Psoriasis
February 2026 | Volume 25 | Issue 2 | Supplement Individual Articles | 070210s3 | Copyright © February 2026
Background: Deucravacitinib, a first-in-class, oral, selective TYK2 inhibitor, has redefined systemic therapy options for moderate-to-severe plaque psoriasis. This review synthes...
Read MorePractical Algorithm for Acne Treatment Integrating Skincare and Energy-Based Devices
February 2026 | Volume 25 | Issue 2 | Original Article | 111 | Copyright © February 2026
Background: Energy-based devices (EBDs) are increasingly used to manage acne and its sequelae. While literature supports the use of appropriate skin care for acne, few studies ad...
Read MoreEfficacy and Safety of Clascoterone Cream 1% for Acne Are Independent of Age and Sex
February 2026 | Volume 25 | Issue 2 | Original Article | 119 | Copyright © February 2026
Acne vulgaris is an inflammatory skin condition affecting adolescents and adults of both sexes. Clascoterone cream 1% is indicated for the topical treatment of acne vulgaris in patients ≥12 ye...
Read MoreWhat Drives the Aesthetic Journey? A Survey of the Cosmetic Concerns for African-American Women
February 2026 | Volume 25 | Issue 2 | Features | 181 | Copyright © February 2026
Treatment of Generalized Granuloma Annulare With Biologics and Oral JAK Inhibitors: A Case Series
February 2026 | Volume 25 | Issue 2 | Features | e26 | Copyright © February 2026
Reddit Discourse on Eczema: Quantitative Analysis of Misinformation, Engagement, and Alignment With 2025 American Academy of Dermatology Guidelines
February 2026 | Volume 25 | Issue 2 | Features | e30 | Copyright © February 2026






